|
|
||||||||
PUBLIC HEALTH MATTERS |
The author is with the University of California at Berkeley and a senior fellow at The Rockridge Institute, Berkeley.
Correspondence: Requests for reprints should be sent to George P. Lakoff, PhD, 1203 Dwinelle Hall, University of California at Berkeley, Berkeley, CA 94720-2650 (e-mail: lakoff{at}uclink.berkeley.edu).
Our system of justice requires that trials be maximally fair. It is part of what holds this society together. Indeed, it is part of the genius of the justice system to have a kind of balance between strict and nurturant morality within the judicial system, so that the system itself provides a kind of moral and political balance.
Daubert v Merrell Dow Pharmaceuticals, Inc (1993) has upset that balance and has made our judicial system significantly less fair and more politically conservative. Daubert is not just about the application of some procedural rule (Rule 702). Daubert functions in its application as a strategic initiative that significantly moves America in a conservative direction, in the moral and political spheres, as well as in the legal sphere.
This article has been cited by other articles:
![]() |
N Wander and R E Malone Fiscal versus social responsibility: how Philip Morris shaped the public funds divestment debate Tob. Control, June 1, 2006; 15(3): 231 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Michaels Scientific Evidence and Public Policy Am J Public Health, July 1, 2005; 95(S1): S5 - S7. [Full Text] [PDF] |
||||
![]() |
R. L. Melnick A Daubert Motion: A Legal Strategy to Exclude Essential Scientific Evidence in Toxic Tort Litigation Am J Public Health, July 1, 2005; 95(S1): S30 - S34. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |